| Patents for C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480) |
|---|
| 10/05/2011 | CN101160338B Monomers, oligomers and polymers comprising thiophene and selenophene |
| 09/28/2011 | CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/01/2011 | WO2011105700A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 08/31/2011 | CN1805955B Oxime ester compound and photopolymerization initiator containing such compound |
| 08/30/2011 | US8008499 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof |
| 07/19/2011 | US7982030 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
| 07/14/2011 | WO2011082566A1 A fluorescent dye, its preparation method and use thereof |
| 07/06/2011 | CN102115610A Fluorescent dye, preparation method and application thereof |
| 06/23/2011 | WO2011073299A1 Pyridinyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 06/15/2011 | CN101585820B 1,2,3-selenadiazole thioacetanilides derivatives, preparation method thereof and application thereof |
| 06/08/2011 | EP1817312B1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/26/2011 | WO2011060526A1 Fluorinated monomers, oligomers and polymers for use in organic electronic devices |
| 05/26/2011 | CA2781316A1 Fluorinated monomers, oligomers and polymers for use in organic electronic devices |
| 05/25/2011 | EP2325179A1 Glycosidase ihhibitors and preparation thereof |
| 05/24/2011 | CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors |
| 05/12/2011 | WO2011054290A1 Methods and reagent kits for determining the activity of thioredoxin reductase and the uses thereof |
| 04/26/2011 | CA2462416C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 04/14/2011 | US20110083730 Derivatives or dipyrannylidene type as anode interface layer in electronic devices |
| 04/05/2011 | US7919511 Aminopyridines, e.g., 6-(2-cyanophenyl)-4-{[2-(3-fluorophenyl)ethyl]amino}(3-pyridyl))-N-(3-pyridylmethyl)carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, COPD, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction |
| 03/08/2011 | US7901894 Kinase inhibitors |
| 03/01/2011 | US7897776 Sulfonamide containing compounds for treatment of inflammatory disorders |
| 12/30/2010 | US20100331368 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents |
| 12/16/2010 | US20100314615 Aromatic amine derivative and organic electroluminescent device using the same |
| 12/09/2010 | WO2010140802A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 12/07/2010 | US7846945 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents |
| 11/18/2010 | WO2010132524A1 2-azatriphenylene materials for organic light emitting diodes |
| 11/09/2010 | US7829563 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide |
| 10/26/2010 | US7820829 1,2-Bis[(1,2)-benzisoselenazol-3(2H)-onyl]ethane; high anti-oxidative activity and low toxicity; in combination with other anticarcinogenic, anticoagulant, antiinflammatory agents ( cisplatin, adriamycin, taxol; aspirin; indometacin) |
| 09/28/2010 | US7803799 such as 1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-5-(selenophen-2-yl)-1H-pyrazole-3-carboxamide, used for treating cannabinoid-receptor mediated disorders selected from obesity, metabolic syndrome, drug abuse and dependence or neuropathic pain |
| 09/21/2010 | US7799778 5-substituted 2-aminopyridine analogs for treating allergic and inflammatory diseases |
| 08/31/2010 | US7786310 Small molecule transcriptional activation domains |
| 08/31/2010 | US7786141 Treating neurodegenerative diseases, psychological disorders, pain, glaucoma, dru eye, dry mouth, Sjogren's syndrome, asthma, bradycardia, wound healing, gastrointestinal disorders; amide- or urea-functional C5.C5N.C6 SPIRO(INDENE-2,4'-PIPERIDINE) RING structures; selective as to subtypes M1-M5 |
| 08/24/2010 | US7781590 2-(methylamino)-2-oxoethyl 2-[1-(biphenyl-4-ylmethyl)piperidin-4-yl]ethylcarbamate; interacting with cannabinoid and vanilloid receptors; preparation by aminolysis of a 3-(2-piperidin-4-ylethyl)-1,3-oxazolidine-2,4-dione |
| 08/17/2010 | US7776888 such as 3-[2-(2-methoxy-ethoxymethyl)-6-trifluoromethyl-pyridine-3-carbonyl]-1,5-dimethyl-8-oxa-bicyclo[3.2.1]oct-6-ene-2,4-dione, used for controlling undesired plant growth or weeds |
| 08/17/2010 | US7776876 administering cyclic Glycyl-2-Allyl Proline as as neuroprotectants, for the prophylaxis of nervous system disorders |
| 08/10/2010 | US7771820 using super molecules obtainable by integrating weak reversible interactions acting between molecules and organizing the molecules into a regulated collection; conductive molecules are selected from cation radical salts, anion radical salts, organic compounds |
| 07/21/2010 | CN101781283A Thioredoxin reductase inhibiter compounds and preparation method and application thereof |
| 07/13/2010 | US7754727 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents |
| 07/01/2010 | US20100168064 Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents |
| 06/22/2010 | US7741316 Pharmacological uses of azetidine derivatives |
| 06/15/2010 | US7737272 Diazaphosphacycle transition metal complexes |
| 05/26/2010 | CN1690057B Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging |
| 05/06/2010 | WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 04/13/2010 | US7696257 Oxime ester compound and photopolymerization initiator containing such compound |
| 03/10/2010 | EP1780209B1 Oxime ester compound and photopolymerization initiator containing such compound |
| 02/09/2010 | CA2287370C Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides |
| 11/25/2009 | CN101585820A 1,2,3-selenadiazole thioacetanilides derivatives, preparation method thereof and application thereof |
| 10/14/2009 | CN101555246A Halogen-containing asymmetry phthalocyanines compound, preparation method and application thereof |
| 10/13/2009 | US7601859 Organometallic complexes |
| 10/06/2009 | US7598389 Silylated carboxamides |
| 10/06/2009 | US7598236 Diazabicyclic central nervous system active agents |
| 09/29/2009 | US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 09/22/2009 | US7592446 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
| 09/22/2009 | US7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 08/25/2009 | US7579478 Process for the purification of substituted benzoxazole compounds |
| 08/12/2009 | CN100526323C 铑和铱的络合物 Complexes of rhodium and iridium |
| 07/14/2009 | US7560554 fac-Bis[2-(2-pyridinyl- kappa N)phenyl- kappa C]-[2-(2-pyridinyl- kappa N)(5-formylphenyl)- kappa C]-iridium(III); phosphorescence emitters; organic light-emitting diode, an organic integrated circuit, an organic field effect transistor, an organic thin-film transistor, an organic solar cell |
| 06/23/2009 | CA2362728C Improved aqueous solubility pharmaceutical formulations |
| 06/16/2009 | US7547782 Met kinase inhibitors |
| 06/04/2009 | WO2009051796A3 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents |
| 05/07/2009 | WO2006047277A3 Inhibitors of c-fms kinase |
| 04/28/2009 | US7524864 Methods of treating sleep disorders |
| 04/23/2009 | WO2009051796A2 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents |
| 03/31/2009 | US7511064 Treating conditions alleviated by 5-HT2B antagonists such as migraine, gastrointestinal disorders; restenosis, asthma, obstructive airway disease, bronchial pulmonary dysplasia, prostatic hyperplasia and priapism; hypotensive agents |
| 03/26/2009 | WO2005067580A3 Naphthofluorescein-based metal sensors, and methods of making and using the same |
| 03/17/2009 | US7504520 8-({5-[4-(trifluoromethyl)phenyl]-1,3-oxazol-2-yl}amino)-3,4-dihydronaphthalen-2(1H) one; treating pain, bladder overactivity, and urinary incontinence |
| 02/24/2009 | US7495019 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 02/17/2009 | US7491736 Use as bronchodilators for treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-([4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino)ethyl)piperidin-4-yl ester |
| 02/12/2009 | US20090043103 Organic dye used in dye-sensitized solar cell |
| 01/27/2009 | US7482345 P38 kinase inhibiting agents |
| 12/18/2008 | WO2008043072A3 Cd80 antagonists for treating neoplastic disorders |
| 12/11/2008 | US20080303000 Monomers, Oligomers and Polymers Comprising Thiophene and Selenophene |
| 11/06/2008 | US20080275086 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 11/04/2008 | US7446114 minimal side effects, improved selectivity, potency, pharmacokinetics, and/or duration of action; 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-(4-methanesulfonylpiperazine-1-sulfonyl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; reduced motility of the gastrointestinal tract |
| 10/30/2008 | WO2008030408A3 Proteomimetic compounds as inhibitors of the interaction of a nuclear receptor with coactivator peptides |
| 09/30/2008 | US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents |
| 08/12/2008 | US7410961 2,6-disubstituted piperiddines as modulators |
| 08/06/2008 | EP1953155A2 Composition containing thiazole rings, organic semiconductor polymer containing the composition, organic active layer containing the organic semiconductor polymer, organic thin film transistor containing the organic active layer, electronic device containing the organic thin film transistor and method of preparing the same |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407948 as anticarcinogenic, antibacterial and antiinfective agent in in vivo photodynamic therapy (PDT); 3,7-Bis-(N,N-dipentylamino)phenoselenazin-5-ylium iodide |
| 07/10/2008 | WO2007117558A3 Antioxidants and methods of their use |
| 06/19/2008 | US20080146619 Certain chemical entities, compositions, and methods |
| 06/12/2008 | US20080139562 e.g. {-[3-Cyclopentyl-2-(4-methane sulfonyl-phenyl)-propionylamino]-5-methyl-thiazol-4-yl}-acetic acid ethyl ester; antidiabetic and hypoglycemic agent; non-insulin dependent diabetis, obesity, impaired glucose tolerance, eating disorder, dyslipidemia, hyperlipidemia, hypertension |
| 06/10/2008 | US7384388 Styryl dyes with linker |
| 06/03/2008 | US7381723 Antiserotonine agents; stroke, brain disorders;trauma; Alzheimer's disease; neurodegenerative disease; schizophrenia; psychological disorders; anxiolytic agents; controlling stresses; eating disorders; sleep disorders; sexual disorders |
| 05/29/2008 | US20080124545 Monocrystal, Nano Wire Material, Electronic Element, and Method of Producing Nano Wire Material |
| 04/09/2008 | CN101160338A Monomers, oligomers and polymers comprising thiophene and selenophene |
| 03/25/2008 | CA2164642C Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 02/27/2008 | CN101130540A Nucleoside derivative containing selenium and its preparation method |
| 01/24/2008 | US20080021031 Selenophene compounds |
| 12/27/2007 | WO2007117565A9 Standardization of processes for culturing primary cells |
| 12/18/2007 | CA2217074C Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis |
| 11/29/2007 | US20070275944 Antioxidants and methods of their use |
| 11/27/2007 | US7301028 Mitotic kinesin inhibitors |
| 11/27/2007 | US7300931 Compositions for treating cell proliferation disorders |
| 11/21/2007 | EP1856178A1 Monomers, oligomers and polymers comprising thiophene and selenophene |
| 11/06/2007 | US7291632 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists |
| 10/31/2007 | CN100345843C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 10/24/2007 | CN101061119A Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 10/24/2007 | CN101061096A Cycloalkyl keto piperidine tachykinin receptor antagonists |